These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10578316)

  • 21. Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation.
    Gonzalez E; Ettenger R; Rianthavorn P; Tsai E; Malekzadeh M
    Pediatr Transplant; 2011 Aug; 15(5):495-501. PubMed ID: 21338460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review.
    Vinai M; Waber P; Seikaly MG
    Pediatr Transplant; 2010 May; 14(3):314-25. PubMed ID: 20519016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal Revival: The Hidden Benefit of Antirejection Medications.
    Koratala A; Kazory A
    Transplantation; 2018 Nov; 102(11):e481-e482. PubMed ID: 30048395
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
    Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation.
    Apeland T; Hartmann A
    Nephrol Dial Transplant; 2008 Jun; 23(6):2091-4. PubMed ID: 18319357
    [No Abstract]   [Full Text] [Related]  

  • 26. Recurrent focal segmental glomerulosclerosis after renal transplantation.
    Datta AR; Sakhuja V; Minz M; Joshi K; Chugh KS
    Int J Artif Organs; 1991 Feb; 14(2):99-101. PubMed ID: 2037398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation.
    Audard V; Kamar N; Sahali D; Cardeau-Desangles I; Homs S; Remy P; Aouizerate J; Matignon M; Rostaing L; Lang P; Grimbert P
    Transpl Int; 2012 May; 25(5):e62-6. PubMed ID: 22409658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histological injury and renal transplant outcome: the cumulative damage hypothesis.
    Nankivell BJ; Kuypers DR; Fenton-Lee CA; Allen RD; O'Connell PJ; Chapman JR
    Transplant Proc; 2001; 33(1-2):1149-50. PubMed ID: 11267231
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis.
    Moroni G; Gallelli B; Quaglini S; Banfi G; Montagnino G; Messa P
    Transpl Int; 2010 Feb; 23(2):208-16. PubMed ID: 19793073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy.
    Suzuki K; Tanabe K; Tokumoto T; Shimizu T; Ishikawa N; Yagisawa T; Honda K; Nihei H; Toma H
    Transplant Proc; 2000 Nov; 32(7):1730-2. PubMed ID: 11119910
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term outcome in simultaneous kidney and pancreas transplant recipients with functioning allografts at 1-year posttransplantation.
    Peddi VR; Munda R; Demmy AM; First MR
    Transplant Proc; 1999; 31(1-2):608-9. PubMed ID: 10083257
    [No Abstract]   [Full Text] [Related]  

  • 32. Five year outcome of tacrolimus rescue therapy in late rejection after renal transplantation.
    Budde K; Smettan S; Fritsche L; Waiser J; Neumayer HH
    Transplant Proc; 2002 Aug; 34(5):1594-6. PubMed ID: 12176499
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term outcomes in simultaneous kidney-pancreas transplant recipients.
    Stratta RJ; Sudan R; Sudan D
    Transplant Proc; 1998 Jun; 30(4):1564-5. PubMed ID: 9636635
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term outcome of kidney transplantation in adult recipients with focal segmental glomerulosclerosis.
    Choi KH; Kim SI; Yoon SY; Kim JH; Kang SW; Ha SK; Lee HY; Han DS; Kim YS; Park K; Jeong HJ; Kim DK
    Yonsei Med J; 2001 Apr; 42(2):209-14. PubMed ID: 11371109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful Treatment With Abatacept in Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplant.
    Shah Y; Almeshari K; Aleid H; Broering D; Alahmadi I; Ali T
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):178-180. PubMed ID: 30777550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of race in kidney transplant outcomes in children with focal segmental glomerulosclerosis.
    Guan I; Singer P; Frank R; Chorny N; Infante L; Sethna CB
    Pediatr Transplant; 2016 Sep; 20(6):790-7. PubMed ID: 27460535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The different patterns of response to plasmapheresis of recurrent focal and segmental glomerulosclerosis.
    Ponticelli C; Campise M; Tarantino A
    Transplant Proc; 2002 Dec; 34(8):3069-71. PubMed ID: 12493377
    [No Abstract]   [Full Text] [Related]  

  • 38. Focal segmental glomerulosclerosis in pediatric kidney transplantation: 30 years' experience.
    Cleper R; Krause I; Bar Nathan N; Mor M; Dagan A; Weissman I; Frishberg Y; Rachamimov R; Mor E; Davidovits M
    Clin Transplant; 2016 Oct; 30(10):1324-1331. PubMed ID: 27490751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Outcomes of Kidney Transplant Recipients With Primary Idiopathic Focal Segmental Glomerulosclerosis.
    Staeck O; Halleck F; Budde K; Khadzhynov D
    Transplant Proc; 2017 Dec; 49(10):2256-2259. PubMed ID: 29198656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent focal glomerulosclerosis in renal allografts.
    Garcia V; Abbud-Filho M; Keitel E; Neumann J; Goldani JC
    Transplant Proc; 1995 Feb; 27(1):1084-5. PubMed ID: 7878814
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.